Results 261 to 270 of about 302,269 (383)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Journal of the American Medical Association (JAMA), 1999
R. Turner, C. Cull, V. Frighi, R. Holman
semanticscholar   +1 more source

Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer and is frequently identified at a late stage, necessitating systemic therapy. However, resistance to first‐line tyrosine kinase inhibitor therapies, such as sorafenib and lenvatinib, remains a significant clinical challenge.
Longtao Zhao, Junjie Cheng, Yiming Zheng, Jing Wu, Jia Fan, Haixiang Sun, Chao Gao   +6 more
wiley   +1 more source

Microneedling-assisted delivery of metformin versus tranexamic acid in treating melasma: a randomized controlled study. [PDF]

Eur J Med Res
Al Mohammady A, Kadah AS, Mahran MA, Elsaie ML.   +3 more
europepmc   +1 more source

Inhibition of leptin secretion by insulin and metformin in cultured rat adipose tissue

, 2000
Gail J. Mick, Xudong Wang, Chang Ling Fu, Kenneth McCormick   +3 more
openalex   +1 more source

Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes [PDF]

, 2001
Mette Zander, Mustafa Taskiran, M. Toft-Nielsen, Sten Madsbad, Jens J. Holst   +4 more
openalex   +1 more source

Maternal diabetes mellitus during pregnancy as a risk factor for strabismus and refractive errors in the offspring—A large‐scale national study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate whether maternal diabetes during pregnancy is associated with increased risk of strabismus and refractive errors (RE) in their offspring. Methods This retrospective cohort study utilized electronic medical records from Clalit Health Services (CHS) in Israel, 2001–2023. Births were categorized by maternal diabetes type (
Nir Amitai, Tomer Kerman, Tamar Eshkoli, Ahed Imtirat, Amichai Raz, Itamar Ben Shitrit, Dor Marciano, Eyal Sheiner, Erez Tsumi   +8 more
wiley   +1 more source

Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy. [PDF]

Oxid Med Cell Longev
B Ramegowda L, Vishwanath P, V Salimath P, S Shetty M, K Marulaiah S, C Ramachandra S, Prashant A.   +6 more
europepmc   +1 more source

Effect of metformin on mouse embryo development [PDF]

, 2001
Mohamed A. Bedaiwy, K.F. Miller, Jeffrey M. Goldberg, Tommaso Falcone, David R. Nelson   +4 more
openalex   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

iMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu, Yu An, Yage Du, Zhaoming Cao, Jie Zheng, Jingya Wang, Tingyi Li, Xingen Lei, Yanhui Lu   +8 more
wiley   +1 more source

Metformin use on the risks of depression and anxiety in people with type 2 diabetes. [PDF]

Commun Med (Lond)
Kang M, Liu H, Hui J, Gou Y, Zhou R, Liu Y, Liu C, Shi P, Wang B, Wen Y, Cheng B, Jia Y, Li C, Zhang F.   +13 more
europepmc   +1 more source